 |
Located in Athens, Georgia, ArunA Biomedical, Inc. is a privately held biotechnology corporation dedicated to the discovery, manufacturing and commercialization of emerging new technologies in human stem cell research for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in understanding human development and diseases.
 |
Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation tools and services for drug discovery, screening, and predictive toxicology. CDI combines the power of human pluripotent stem cells and cardiac toxicity for world class drug development including a GP facility for hERG testing for FDA submissions. CDI was founded in 2005 by Jamie Thomson, a pioneer in human embryonic stem cells from the University of Wisconsin-Madison. CDI's facilities are located in Madison, Wisconsin.
 |
Stemina was founded in late 2006 and opened its facility in the UW Research Park in November 2007 to commercialize hES cell technology based on Dr. Cezar's work at the University of Wisconsin. Human embryonic stem cells offer a unique and never before available opportunity to study the pathways impacted by exposure to toxic compounds or the manifestations of devastating disease. Stemina combines hES cell technology and mass spectrometry to discover and validate small molecules that are biomarkers of toxicity. Our technological capabilities include a state-of-the-art Agilent LC/QTOF-MS system and a strong scientific team. Stemina provides compound screening and diagnostic development for pharmaceutical, biotechnology industries, and academia under contract services or joint discovery agreements using our proprietary metabolomics platform.
